Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2020 | Transplant Patient Selection & MDS 2020 higlights

Theo de Witte • 5 Mar 2020
MDS 2020
Anemias Myelodysplastic Syndromes

Theo de Witte, MD, Radboud University Medical Center, Nijmegen, The Netherlands, discusses transplantation for patients with myelodysplastic syndromes (MDS) and shares his key take-home messages from this year’s meeting. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

More from Theo de Witte

2:15
Optimizing transplantation for MDS
Theo de Witte • 5 Mar 2020
2:05
EUMDS Registry
Theo de Witte • 5 Mar 2020
2:18
Theo de Witte: an MDS transplant pioneer
Theo de Witte • 5 Mar 2020
1:59
MDS pathology and comorbidities
Theo de Witte • 5 Mar 2020

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
3:45
A 2-year analysis of the EBMT-SAAWP RACE trial: eltrombopag in aplastic anemia
Antonio Risitano • 16 Apr 2024
3:19
Key clinical trials in MDS taking place in the US
Guillermo Garcia-Manero • 9 Apr 2024
1:34
Sequencing of agents in LR-MDS
Guillermo Garcia-Manero • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals